Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on Apr 18, 2015 4:20pm
161 Views
Post# 23643668

RE:South east Asia investing

RE:South east Asia investingHi ColdNewfie. - your post Apr 15 at 12:55

Thanks for the excellent perspective. You have expressed my sentiments exactly.China now has many billionnaires and highly internationally and locally educated scientific communities. You can be sure they are highly advanced in leading scientific knowledge.

As I understand it, China holds a huge amount of American debt at this stage and they are heavily invested in many countries including countries in Africa and the Middle East.

If the CNOOC investment in Canada's oil sands is any indication of the Chinese government's willingness to take a position in Canadian oil development, then it is clear they are quite willing to take on huge short term risk for long term gain.

Given the diabetes epidemic in China and given their very good health care system I can only imagine how appealing RVX would be as an opportunity for them to jump in and eastablish leadership in epigenetics.

Thanks again. The posts on this board have really degenerated to little value of insight recently so it was helpful for me to receive your valuable insight.

IMHO       DYODD     GLTA

Cheers
Toinv    :) 
Bullboard Posts